The data was presented at the Orthopaedic Research Society in Long Beach, Calif. The data shows that several antibodies targeting glucosamindase, a protein, found in the Staphylococcus aereus, can lead to the bug’s demise. Dr. Schwarz and his team discovered four anti-Gmd monoclonal antibodies that disrupt the growth of MRSA bacteria.
Read the Pittsburgh Examiner report on the research.
Read other coverage on studies by orthopedic surgeons:
– University of Toledo Receives NFL Charities Grant for Studying MRSA Spread in Artificial Turf
– Research on Infection-Resistant Orthopedic Implants Receives NSF Funding
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
